The new study defines an unexpected mechanism at work in the anti-autoimmune drug candidate ozanimod that helps explain its effectiveness even at low doses.
The findings from the Lander lab shed light on an ion channel’s possible role in immune functions such as detecting infection and inflammation.
Meet Simone Mori, research associate in the Conti lab and president of the Scripps Consulting Club.